Get some tea and settle in, its a long one My personal experience with low-dose semaglutide (GLP-1) in Perimenopause, and why I think this conversation needs way more nuance: Okay, so over the last couple of years (as I moved deeper into my mid-40s) I started noticing something that so many women tell me about but hardly anyone talks about honestly: My appetite changed
[21] [22] GLP-1 agonists available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Bydureon BCise)
Even though most patients tolerate Ozempic well, we still monitor for any side effects, such nausea or gastrointestinal distress, and we encourage open communication with our healthcare providers
Diabetes 63 , 24742485 (2014)